» Articles » PMID: 33445741

Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma-A Retrospective Analysis of a Swedish Cohort

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Jan 15
PMID 33445741
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer where Merkel cell Polyomavirus (MCPyV) contributes to the pathogenesis. In an adjuvant setting, radiotherapy (RT) is believed to give a survival benefit. The prognostic impact of sex related to MCPyV-status and adjuvant RT were analyzed in patients referred to Karolinska University Hospital. Data were collected from 113 patients' hospital records and MCPyV analyses were made in 54 patients (48%). We found a significantly better overall survival (OS) for women compared to men and a significant difference in OS in patients receiving adjuvant RT. Furthermore, we found that men with virus negative MCC have an increased risk for earlier death (HR 3.6). This indicates that MCPyV positive and negative MCC act as two different diseases, and it might be due to different mechanism in the immune response between male and female patients. This could have significance in tailoring treatment and follow-up in MCC patients in the future.

Citing Articles

Effectiveness and Safety of Treatments for Early-Stage Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies.

Mbous Y, Mohamed R, Sambamoorthi U, Bharmal M, Kamal K, LeMasters T Cancer Med. 2025; 14(1):e70553.

PMID: 39749718 PMC: 11696246. DOI: 10.1002/cam4.70553.


A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?.

Preis S, Ziehfreund S, Biedermann T, Horster S, Zink A J Eur Acad Dermatol Venereol. 2024; 39(3):512-528.

PMID: 39078087 PMC: 11851263. DOI: 10.1111/jdv.20256.


Merkel Cell Carcinoma Mimicking a Pyogenic Granuloma on the Thumb.

Fanous R Cureus. 2024; 15(12):e50878.

PMID: 38249166 PMC: 10799242. DOI: 10.7759/cureus.50878.


The impact of merkel cell polyomavirus positivity on prognosis of merkel cell carcinoma: A systematic review and meta-analysis.

Yang A, Wijaya W, Yang L, He Y, Cen Y, Chen J Front Oncol. 2022; 12:1020805.

PMID: 36248985 PMC: 9562919. DOI: 10.3389/fonc.2022.1020805.


Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort study.

Ferrandiz-Pulido C, Gomez-Tomas A, Llombart B, Mendoza D, Marcoval J, Piaserico S J Eur Acad Dermatol Venereol. 2022; 36(11):1991-2001.

PMID: 35607918 PMC: 9796956. DOI: 10.1111/jdv.18256.


References
1.
Zaar O, Gillstedt M, Lindelof B, Wennberg-Larko A, Paoli J . Merkel cell carcinoma incidence is increasing in Sweden. J Eur Acad Dermatol Venereol. 2016; 30(10):1708-1713. DOI: 10.1111/jdv.13698. View

2.
Lanoy E, Engels E . Skin cancers associated with autoimmune conditions among elderly adults. Br J Cancer. 2010; 103(1):112-4. PMC: 2894998. DOI: 10.1038/sj.bjc.6605733. View

3.
Stang A, Becker J, Nghiem P, Ferlay J . The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment. Eur J Cancer. 2018; 94:47-60. PMC: 6019703. DOI: 10.1016/j.ejca.2018.02.003. View

4.
Sahi H, Their J, Gissler M, Koljonen V . Merkel Cell Carcinoma Treatment in Finland in 1986-2016-A Real-World Data Study. Cancers (Basel). 2020; 12(5). PMC: 7281542. DOI: 10.3390/cancers12051224. View

5.
Handschel J, Muller D, Depprich R, Ommerborn M, Kubler N, Naujoks C . The new polyomavirus (MCPyV) does not affect the clinical course in MCCs. Int J Oral Maxillofac Surg. 2010; 39(11):1086-90. DOI: 10.1016/j.ijom.2010.06.024. View